Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Protagenic Therapeutics, Inc.\new

OTC: PTIX · Life Sciences · 2 alerts · CIK 1022899

Share price
$0.4500Close, Nov 16
Market cap
$815K
Shares outstanding
1.81MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Protagenic Therapeutics, Inc.\new filings on SEC EDGAR ↗

2:28 PM ET 10-Q
Financial Results

Protagenic Therapeutics, Inc.\new Q2 2026 Results: Net Loss of $667K, Loss Narrows

Protagenic Therapeutics reported a net loss of $1,630,810 for the six months ended September 30, 2026, compared to a loss of $5,927,010 in the prior year period. The company's cash position significantly decreased from $1,509,178 at March 31, 2026, to $76,909 at September 30, 2026, as it continues to fund research and development and consulting operations.

Key figure
Net loss $667K
2:16 PM ET 8-K
Loan & Debt

Protagenic Therapeutics, Inc.\new Debt Financing Update with Patness LLC

Protagenic Therapeutics issued a $250,000 promissory note to Patness LLC bearing 1.0% annual interest. The debt is due upon the earlier of a future equity capital raise of at least $1 million or 180 days from the issuance date. Interest is forgiven if the principal is repaid within 365 days.

Counterparty
Patness LLC
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.